Echocardiographic Evaluation in Liver Transplantation
Do pre-liver transplant echocardiographic indices accurately predict post-liver transplant morbidity and mortality?
Category : Organ Transplants & Donation : Health & Medical
Belatacept May Change Kidney Transplantation Medicine
A novel agent, belatacept, may preserve renal function and improve long-term outcomes better than calcineurin inhibitors in kidney transplantation. Dr. Ron Shapiro discusses 2 pivotal trials.
Ask the Experts - Hepatitis C After Kidney Transplantation?
What about liver transplantation in this patient?
Use of Octogenarian Donors for Liver Transplantation
Use of very old donors in liver transplantation is controversial, but should some older livers be considered?
Kidney Transplant Recipient With DVT
How long should anticoagulant therapy be given to a renal transplant recipient with deep venous thrombosis?
Ask the Experts - Cyclosporine Neurotoxicity?
We have a 51-year-old patient with alcoholic cirrhosis, postoperative day 21 after liver transplantation, with cyclosporine (CsA) neurotoxicity (seizures and stupor). CsA levels are therapeutic levels (300-400). How do you decrease the dose, what parameters do you use, and what is the best target ra
Ask the Experts - Renal Transplantation in a Hemophiliac?
Do you have experience with successful management of renal transplantation in a hemophilic recipient?
Ask the Experts - Polyomavirus in Renal Allograft Biopsies?
How common is polyomavirus (BKV) in renal allograft biopsies and what are the reliable differentiation points with respect to tubulo-interstitial rejection?
Biliary Complications After Liver Transplantation
Get updated on the latest means of prevention and treatment of biliary complications, a major source of morbidity after liver transplantation.
Kidney Donor Profile Index of Marginal Donors
Find out how marginal donor allocation puts more kidneys to work for patients awaiting kidney transplant.
Diagnosis and Management of Antibody-Mediated Rejection
Learn more about the spectrum of antibody-mediated rejection after kidney transplantation, including its pathogenesis, risk factors, and phenotypes.
Kidney Transplant Recipient With Testicular Cancer
How should I manage immunosuppression in a kidney transplant recipient with stage I testicular cancer?
Plasma Cell Neoplasms in Organ Transplant Recipients
Transplant recipients have elevated risk for plasma cell neoplasms but what is known about risk factors in the transplant setting?
Potential Markers for Chronic Allograft Dysfunction
Dr. Ron Shapiro reports on whether the expression of intratubular vimentin and CD44 in 6-month protocol biopsies is a marker for development of interstitial fibrosis and tubular atrophy.
Elderly Patients and Elderly Donors
Two studies support the concept of donor and recipient age-adapted immunosuppression.
May 2003: The Bartered Kidney: Organ of Last Resort?
The international trade route for the human organ black market that Dr. Scheper-Hughes and colleagues have chronicled is mind-boggling.
Renal Transplantation in the Elderly?
Is a 69-year-old man with stable chronic renal insufficiency, on dialysis for 2 years, a kidney transplant candidate?
Valganciclovir vs Intravenous Ganciclovir, Revisited
On September 15, the Food and Drug Administration changed the indications for valganciclovir (Valcyte) to include prevention of CMV disease in kidney, pancreas, and heart transplant patients.
Echocardiographic Evaluation in Liver Transplantation
Do pre-liver transplant echocardiographic indices accurately predict post-liver transplant morbidity and mortality?
Retransplantation in Patient With Recurrent MPGN?
Is it reasonable to retransplant a patient who lost his graft due to recurrent MPGN type 2?